ORMP
Oramed Pharmaceuticals Inc
Price:  
2.10 
USD
Volume:  
117,830.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORMP Intrinsic Value

-264.59 %
Upside

What is the intrinsic value of ORMP?

As of 2025-07-01, the Intrinsic Value of Oramed Pharmaceuticals Inc (ORMP) is -3.46 USD. This ORMP valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.10 USD, the upside of Oramed Pharmaceuticals Inc is -264.59%.

Is ORMP undervalued or overvalued?

Based on its market price of 2.10 USD and our intrinsic valuation, Oramed Pharmaceuticals Inc (ORMP) is overvalued by 264.59%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

2.10 USD
Stock Price
-3.46 USD
Intrinsic Value
Intrinsic Value Details

ORMP Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -3.46 - -3.46 -3.46 -264.59%
P/E (13.22) - (12.62) (13.25) -731.2%
DDM - Stable (5.39) - (20.95) (13.17) -727.2%
DDM - Multi (3.19) - (10.07) (4.90) -333.2%

ORMP Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 85.78
Beta 0.37
Outstanding shares (mil) 40.85
Enterprise Value (mil) 11.27
Market risk premium 4.60%
Cost of Equity 9.97%
Cost of Debt 5.00%
WACC 6.82%